NCT04111770 - The OPTIMAL Randomized Controlled Trial | Biotech Hunter

Enrollment

807

Participants

Timeline

Start Date

July 8, 2020

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions

Left Main Coronary Artery Stenosis

Interventions

DEVICE

IVUS guided Percutaneous Coronary Intervention

Pre-procedural IVUS will be used to determine lesion characteristics and post-procedural IVUS to confirm correct implantation of stent.

DEVICE

QCA guided Percutaneous Coronary Intervention

QCA will be used to determine lesion characteristics

Trial Locations (28)

Unknown

ASST Papa Giovanni XXIII, Bergamo

A.O.U. di Ferrara, Ferrara

Interventistica Cardiologica Strutturale, Florence

ASST Niguarda, Milan

Policlinco San Donato, Milan

Sant'Ambrogio Clinical Institute, Milan

Policlinico Umberto I, Rome

AOUI Verona, Verona

Hospital Universitario de A Coruña, A Coruña

Hospital de Bellvitge, Barcelona

Hospital Vall d´Hebron, Barcelona

Hospital Reina Sofia, Córdoba

Hospital de Cabueñes, Gijón

Hospital Clinico San Carlos, Madrid

Hospital Clinico Universiatrio V. Arrixaca, Murcia

Hospital Universitario Marqués de Valdecilla, Santander

Hospital Alvaro Cunqueiro, Vigo

Hospital Clinico Lozano Blesa, Zaragoza

Royal Victoria Hospital, Belfast

Royal Bournemouth Hospital, Bournemouth

Royal Sussex Country Hospital, Brighton

Bristol Royal infirmary, Bristol

University Hospital of Wales, Cardiff

Golden Jubilee National Hospital, Clydebank

Leeds General Infirmary, Leeds

St Bartholomew's Hospital, London

The Freeman Hospital, Newcastle upon Tyne

John Radcliffe Hospital, Oxford